Autor(es): Lindo, Jorge ; Nogueira, Célia ; Soares, Rui ; Cunha, Nuno ; Almeida, Maria Rosário ; Rodrigues, Lisa ; Coelho, Patrícia ; Rodrigues, Francisco ; Cunha, Rodrigo A. ; Gonçalves, Teresa O.
Data: 2024
Identificador Persistente: http://hdl.handle.net/10400.11/9029
Origem: Repositório Científico do Instituto Politécnico de Castelo Branco
Assunto(s): Adenosine A2A receptor; ATP P2X7 receptor; COVID-19; SARS-CoV-2; Polymorphisms
SARS-CoV-2 infection ranges from mild to severe presentations, according to the intensity of the aberrant inflammatory response. Purinergic receptors dually control the inflammatory response: while adenosine A2A receptors (A2ARs) are anti-inflammatory, ATP P2X7 receptors (P2X7Rs) exert pro-inflammatory effects. The aim of this study was to assess if there were differences in allelic and genotypic frequencies of a loss-of-function SNP of ADORA2A (rs2298383) and a gain-of-function single nucleotide polymorphism (SNP) of P2RX7 (rs208294) in the severity of SARS-CoV-2-associated infection. Fifty-five individuals were enrolled and categorized according to the severity of the infection. Endpoint genotyping was performed in blood cells to screen for both SNPs. The TT genotype (vs. CT + CC) and the T allele (vs. C allele) of P2RX7 SNP were found to be associated with more severe forms of COVID-19, whereas the association between ADORA2A SNP and the severity of infection was not significantly different. The T allele of P2RX7 SNP was more frequent in people with more than one comorbidity and with cardiovascular conditions and was associated with colorectal cancer. Our findings suggest a more prominent role of P2X7R rather than of A2AR polymorphisms in SARS-CoV-2 infection, although larger population-based studies should be performed to validate our conclusions.
